Free Services

MONITOR KEYWORDS

Enter keywords & we'll notify you when a new patent matches your request (weekly update).

ORGANIZER

Save & organize patents so you can view them later.

CUSTOM RSS

Create custom RSS feeds. Track keywords without receiving email.

ARCHIVE

View the last few months of your Keyword emails.

POPULAR PATENTS

Nmda receptor antagonist formulation with reduced neurotoxicity

Abstract: The present invention is directed to pharmaceutical compositions of effective amounts of NMDA receptor antagonists and preservative for the administration to a patient in need of effective analgesia and anesthesia. The compositions of the invention advantageously do not cause any significant neurotoxicity. The preferred NMDA receptor antagonist is ketamine. The preferred preservative is benzalkonium chloride. ...

Agent: Baker Botts L.L.P. - New York, NY, US
Inventors: Fred H. Mermelstein, Randi Albin
USPTO Applicaton #: #20080041367 - Class: 128200140 (USPTO)

Related Terms: Analgesia Anesthesia Benzalkonium Chloride Ketamine Neurotoxic Nmda Nmda Receptor Related Patent Categories: Surgery, Liquid Medicament Atomizer Or Sprayer
The Patent Description & Claims data below is from USPTO Patent Application 20080041367, Nmda receptor antagonist formulation with reduced neurotoxicity.

Analgesia Anesthesia Benzalkonium Chloride Ketamine Mda Neurotoxic Nmda Nmda Receptor

You can also Monitor Keywords and Search for tracking patents relating to this Nmda receptor antagonist formulation with reduced neurotoxicity patent application.
###

Other recent patent applications listed under the agent Baker Botts L.L.P.:

20090322405 - Enhanced transistor gate drive
20090327682 - System and method for transferring configuration information to an embedded device using a command line interface
20090319650 - System and method for the process management of a data center
20090319836 - System and method for recovery from uncorrectable bus errors in a teamed nic configuration
20090308814 - Magnetic purification of a sample
20090309629 - Programmable cycle state machine interface
20090311219 - Oncolytic adenoviruses for cancer treatment
20090301613 - Low yield ratio dual phase steel linepipe with superior strain aging resistance
20090307512 - System and method for managing blades after a power supply unit failure
20090307514 - System and method for managing power supply units
20090297530 - Herv-k antigens, antibodies, and methods

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.
Start now! - Receive info on patent apps like Nmda receptor antagonist formulation with reduced neurotoxicity or other areas of interest.
###

Previous Patent Application:
Method of obtaining an organic salt or acid from an aqueous sugar stream
Next Patent Application:
Aerosol formulation for the inhalation of beta agonists
Industry Class:
Surgery

###

Design/code © 2012 FreshContext LLC/Freshpatents.com.
Patent data source: patents published by the United States Patent and Trademark Office (USPTO)
Information published here is for research/educational purposes only (and in conjunction with our Keyword Monitor) and is not meant to be used in place of the full USPTO patent document/images or a comprehensive patent archive search. Complete official applications are on file at the USPTO and may contain additional data/images. FreshPatents.com is not affiliated with or endorsed by the USPTO or firms/individuals or products/designs/ideas related to listed patents and there may be applicable trademarks or servicemarks within the documents.

FreshPatents.com Support - Terms & Conditions
Thank you for viewing the Nmda receptor antagonist formulation with reduced neurotoxicity patent info.
- - - AAPL - Apple, BA - Boeing, GOOG - Google, IBM, JBL - Jabil, KO - Coca Cola, MOT - Motorla

Results in 0.33515 seconds

Other interesting Freshpatents.com categories:
Celera Genomics , Cingular Wireless , Colgate-Palmolive , Corning , g2